Revenue
Oncology Revenue
+2.35%
+26.18%
Collaboration Revenue
+0.14%
+1.42%
BioPharmaceuticals V&I Revenue
-0.56%
-5.43%
Rare Disease Revenue
-1.58%
-14.71%
BioPharmaceuticals: CVRM Revenue
-0.43%
-4.21%
COVID-19 Revenue
-1.73%
-16.04%
Revenue by Geography
The Americas Revenue
+3.25%
+37.63%
Asia, Africa & Australasia Revenue
+0.69%
+7.07%
Rest of Europe Revenue
+0.14%
+1.37%
EBIT by Geography
Rest of Europe Operating Profit
+2.22%
+24.52%
UK Operating Profit
+1.36%
+14.47%
Asia, Africa & Australasia Operating Profit
+0.77%
+7.94%
The Americas Operating Profit
-0.2%
-2.01%
Capital Expenditures by Geography
The Americas Assets Acquired
+0.18%
+1.84%
Asia, Africa & Australasia Assets Acquired
+3.59%
+42.29%
UK Assets Acquired
-1.51%
-14.07%
Rest of Europe Assets Acquired
-2.1%
-19.14%
